Your browser doesn't support javascript.
loading
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
Acheson, Liam S; Ezard, Nadine; Lintzeris, Nicholas; Dunlop, Adrian; Brett, Jonathan; Rodgers, Craig; Gill, Anthony; Christmass, Michael; McKetin, Rebecca; Farrell, Michael; Shoptaw, Steve; Siefried, Krista J.
Afiliação
  • Acheson LS; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia; Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia; The National Centre for Clinical Research on Emerging Drugs (NCCRED), c/o the University of New South Wales, Sydney,
  • Ezard N; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia; Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia; The National Centre for Clinical Research on Emerging Drugs (NCCRED), c/o the University of New South Wales, Sydney,
  • Lintzeris N; New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN), NSW, Australia; The Langton Centre, South East Sydney Local Health District, Sydney, Australia; Discipline of Addiction Medicine, the University of Sydney, Sydney, Australia.
  • Dunlop A; New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN), NSW, Australia; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, Australia; School of Medicine and Public Health, the University of Newcastle, Newcastle, Australia.
  • Brett J; Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, Australia; St. Vincent's Clinical School, the University of New South Wales, Sydney, Australia.
  • Rodgers C; Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia.
  • Gill A; Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia.
  • Christmass M; Next Step Drug and Alcohol Services, Perth, Australia; National Drug Research Institute, Curtin University, Perth, Australia.
  • McKetin R; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia.
  • Farrell M; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia.
  • Shoptaw S; Department of Family Medicine, The University of California Los Angeles, Los Angeles, USA.
  • Siefried KJ; The National Drug and Alcohol Research Centre (NDARC), the University of New South Wales, Sydney, Australia; Alcohol and Drug Service, St Vincent's Hospital Sydney, Sydney, Australia; The National Centre for Clinical Research on Emerging Drugs (NCCRED), c/o the University of New South Wales, Sydney,
Drug Alcohol Depend ; 241: 109692, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36399936
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Transtornos Relacionados ao Uso de Anfetaminas / Alcoolismo / Estimulantes do Sistema Nervoso Central / Metanfetamina Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Transtornos Relacionados ao Uso de Anfetaminas / Alcoolismo / Estimulantes do Sistema Nervoso Central / Metanfetamina Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article